TrialInflammatory bowel diseases2017
Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
William A Faubion et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it